#ai-drug-discovery
#ai-drug-discovery

[ follow ]

#NYCtech Week in Review: 5/4/25 - 5/10/25

Several NYC startups secured significant funding in recent news, indicating a robust ecosystem.

Wonder raised $600M, leading the funding round among several successful startups.

Belfast-based AMPLY Discovery completes 1.5M seed funding

AMPLY Discovery raised $1.75M to develop innovative AI-driven drug discovery therapies targeting cancers and drug-resistant infections in preclinical stages.

fromTechCrunch

4 months ago

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive | TechCrunch

Isomorphic Labs has raised $600 million to enhance its AI drug discovery efforts and support clinical trials.

fromNew York Post

4 months ago

Alphabet's Isomorphic Labs raises $600M in first funding round for AI drug business

"This funding will further turbocharge the development of our next-generation AI drug design engine, help us advance our own programs into clinical development, and is a significant step forward towards our mission of one day solving all disease with the help of AI," Demis Hassabis, Isomorphic Labs founder and chief executive, said in a statement.

London startup

fromTechCrunch

6 months ago

Reid Hoffman's Manas AI raises $24.6M, a fraction of other AI drug discovery startups | TechCrunch

Manas AI, co-founded by Reid Hoffman, is an AI-driven startup focusing on drug discovery for major cancers, raising $24.6 million in seed funding.